WO2004001369A3 - Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate - Google Patents

Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate Download PDF

Info

Publication number
WO2004001369A3
WO2004001369A3 PCT/IN2003/000219 IN0300219W WO2004001369A3 WO 2004001369 A3 WO2004001369 A3 WO 2004001369A3 IN 0300219 W IN0300219 W IN 0300219W WO 2004001369 A3 WO2004001369 A3 WO 2004001369A3
Authority
WO
WIPO (PCT)
Prior art keywords
compound
formula
propionyloxy
difluoro
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2003/000219
Other languages
French (fr)
Other versions
WO2004001369A2 (en
Inventor
Kanaksinh Jesingbhai Jadav
Sudhakar Kambhampati
Trinadha Rao Chitturi
Rajamannar Thennati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharmaceutical Industries Ltd
Original Assignee
Sun Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Ltd filed Critical Sun Pharmaceutical Industries Ltd
Priority to US10/517,944 priority Critical patent/US7208613B2/en
Priority to EP03760856A priority patent/EP1534733A2/en
Priority to AU2003263575A priority patent/AU2003263575A1/en
Publication of WO2004001369A2 publication Critical patent/WO2004001369A2/en
Publication of WO2004001369A3 publication Critical patent/WO2004001369A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Abstract

The present invention provides a convenient process for the preparation of S-fluoromethyl 6a, 9a-difluoro-11b-hydroxy-16a-methyl-17a-propionyloxy-3-oxoandrosta-1, 4-diene-17b-carbothioate, a compound of formula (1), comprising(a) treating 17b-[(N, N-dimethylcarbamoyl)thio]carbonyl-6a,9a-difluoro-11b-hydroxy-16a-methyl-17a-propionyloxy-3-oxoandrosta-1, 4-diene, a compound of formula (3) with alkali metal carbonate-alcohol system to obtain 6a, 9a-difluoro-11b-hydroxy-16a-methyl-17a-propionyloxy-3-oxoandrosta-1, 4-diene-17b-carbothioic acid, a compound of formula (4); (b) reacting the compound of formula (4) with bromofluoromethane to yield the compound of formula (1).The present invention also provides an improved process for preparation of compound of formula (1) comprising (a) reacting 6a, 9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17a-(propionyloxy) androsta-1, 4-dien-17b-carboxylic acid, a compound of formula (2), with N,N-dimethylthiocarbamoyl chloride in an inert aprotic solvent in the presence of an iodide catalyst and a base to give a compound of formula (3), (b) reacting the compound of formula (3) with a hydrosulfide reagent and bromofluromethane to obtain a compound of formula (1).
PCT/IN2003/000219 2002-06-20 2003-06-16 Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate Ceased WO2004001369A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/517,944 US7208613B2 (en) 2002-06-20 2003-06-16 Synthesis of s-fluoromethyl 6α,9α-difluoro-11β-hydroxy-16α-methyl-17α-propionyloxy-3-oxoandrosta-1,4-diene-17β-carbothioate
EP03760856A EP1534733A2 (en) 2002-06-20 2003-06-16 Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate
AU2003263575A AU2003263575A1 (en) 2002-06-20 2003-06-16 Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN544/MUM/2002 2002-06-20
IN544MU2002 2002-06-20
IN387/MUM/2003 2003-04-17
IN387MU2003 2003-04-17

Publications (2)

Publication Number Publication Date
WO2004001369A2 WO2004001369A2 (en) 2003-12-31
WO2004001369A3 true WO2004001369A3 (en) 2004-04-08

Family

ID=30002065

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2003/000219 Ceased WO2004001369A2 (en) 2002-06-20 2003-06-16 Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate

Country Status (4)

Country Link
US (1) US7208613B2 (en)
EP (1) EP1534733A2 (en)
AU (1) AU2003263575A1 (en)
WO (1) WO2004001369A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060019937A1 (en) * 2004-07-26 2006-01-26 Itai Adin Novel crystalline forms of 6alpha, 9alpha -difluoro-11beta-hydroxy-16alpha-methyl-3-oxo-17alpha-propionyloxy-androsta-1,4-diene 17beta-carboxylic acid and processes for preparation thereof
CN100560598C (en) * 2005-07-26 2009-11-18 上海奥锐特国际贸易有限公司 The synthetic method of fluticasone propionate
AR059216A1 (en) * 2006-01-27 2008-03-19 Sun Pharmaceutical Ind Ltd 11B-HYDROXIANDROSTA-4-ENO-3-ONAS
PL2044099T3 (en) 2006-06-14 2012-10-31 Generics Uk Ltd Process for the preparation of s-fluoromethyl-6 ,9 -difluoro-11 -hydroxy-16 -methyl-17 -propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates
US7522073B1 (en) * 2007-11-30 2009-04-21 Qimonda North America Corp. Self-adapted bus inversion
CA2745024A1 (en) * 2008-11-28 2010-06-03 Pronova Biopharma Norge As A composition, with/without at least one easily oxidised component, comprising an edible processed oil or fat mixture, for promoting growth in an animal, preventing oxidative stress, avoiding that fish develop enlarged liver and feed composition
EP2611821A2 (en) 2010-09-01 2013-07-10 Cadila Healthcare Limited Process for preparing fluticasone propionate/furoate
WO2013009591A1 (en) * 2011-07-08 2013-01-17 Pfizer Limited Process for the preparation of fluticasone propionate form 1
MX2015016283A (en) 2013-05-28 2016-03-11 Sun Pharma Advanced Res Co Ltd Methods for treatment of inflammatory conditions using s-[4-(3-fluoro-3-methylbutyryloxy) but-2-ynyl] 6alpha, 9alpha-difluoro-17alpha-(furan-2-yl) carbonyloxy-11beta -hydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta -carbothioate.
US9303060B1 (en) 2014-10-03 2016-04-05 Amphaster Pharmaceuticals, Inc. Methods of preparing intermediate of fluticasone propionate
CN110698530A (en) * 2019-10-30 2020-01-17 山东赛托生物科技股份有限公司 Synthesis method of fluticasone propionate
CN117088932B (en) * 2023-08-22 2026-05-12 黄冈人福药业有限责任公司 Method for treating fluticasone propionate mother liquor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2088877A (en) * 1980-02-15 1982-06-16 Glaxo Group Ltd Androstane 17 beta carbothioates
IL109656A (en) * 1994-05-15 1998-02-22 Chemagis Ltd Process for the manufacture of androstane - 17 - carbothioates and androstane - 17 - carbothioates prepared thereby
WO2001062722A2 (en) * 2000-02-25 2001-08-30 Abbott Laboratories Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE887518A (en) 1980-02-15 1981-08-13 Glaxo Group Ltd ANDROSTAN CARTOTHIOATES

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2088877A (en) * 1980-02-15 1982-06-16 Glaxo Group Ltd Androstane 17 beta carbothioates
IL109656A (en) * 1994-05-15 1998-02-22 Chemagis Ltd Process for the manufacture of androstane - 17 - carbothioates and androstane - 17 - carbothioates prepared thereby
WO2001062722A2 (en) * 2000-02-25 2001-08-30 Abbott Laboratories Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE CASREACT [online] XP002985181, accession no. STN-International, Kalsruhe (DE), CASREACT Database accession no. 129:276096 *

Also Published As

Publication number Publication date
US20050256325A1 (en) 2005-11-17
WO2004001369A2 (en) 2003-12-31
EP1534733A2 (en) 2005-06-01
US7208613B2 (en) 2007-04-24
AU2003263575A8 (en) 2004-01-06
AU2003263575A1 (en) 2004-01-06

Similar Documents

Publication Publication Date Title
CZ20011875A3 (en) Process for preparing acylphosphines, acylphosphine oxides and acylphosphine sulfides
YU44585B (en) Process for obtaining substituted androsta-1,4-dien-3,17-diones
EP1020534A4 (en) Process for synthesizing nucleic acid
MXPA04000449A (en) Process for preparation of amidine derivatives.
IL134875A (en) Method for producing triazolinethione derivatives
EP1275654A3 (en) Process for producing sulfur-containing organosilicon compounds
JP2511281B2 (en) Process for producing 2,6-di-tert-butyl-4-mercaptophenol
EP1262589A3 (en) Door for electric household-appliance and relative electric household-appliance
MX230560B (en)
EP1958938A3 (en) A process for the preparation of 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide
ATE253604T1 (en) COMPACT, TRANSPARENT POLYISOCYANATE POLYADDITION PRODUCTS
AU2002229576A1 (en) Method for producing lipoic acid and dihydrolipoic acid
WO2003013427A3 (en) A method for preparing fluticasone derivatives
WO2004001369A2 (en) Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate
EP0908463A3 (en) Process for preparing polysulfide silanes
HUT59157A (en) Process for producing 4-amino-delta-4'6-steroids
KR960001047A (en) C.I. Manufacturing method of reactive blue 19
US5460806A (en) Bis(2-mercaptoethyl) sulfone
CA2030281A1 (en) Preparation of alkyl alkanethiolsulfonates
AU7042698A (en) Direct synthesis of organo-rhenium oxides from compounds containing rhenium
KR890009884A (en) New way
HUT43836A (en) Process fpr production of derivatives of 2-carboxi-pirasine-4-oxid
IT1299582B1 (en) PROCEDURE FOR THE PREPARATION OF 13-CIS-RETINOIC ACID
BR0008029A (en) Method of producing thiobarbituric acid derivatives
WO2003057855A3 (en) Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10517944

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2003760856

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003760856

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2003760856

Country of ref document: EP